GARY S JACOB Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GARY S JACOB.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GARY S JACOB. GARY S JACOB is in Cardiff Oncology, Inc. ($XNOM.OB) and Director in Trovagene, Inc. ($XNOM.OB) and Chairman and CEO in SYNERGY PHARMACEUTICALS, INC. ($SGYP) and Chief Executive Officer in SYNERGY PHARMACEUTICALS, INC. ($SGYP) and Executive Chairman in SYNERGY PHARMACEUTICALS, INC. ($SGYP) and Director in ContraVir Pharmaceuticals, Inc. ($CTRV) and Director in Virpax Pharmaceuticals, Inc. ($VRPX).
Latest Insider Trading Transactions of GARY S JACOB
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XNOM.OB, HEPA, SGYP, VRPX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 2.48 | 44,734 | 110,940 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 21.60 | 755 | 16,308 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 51.84 | 530 | 27,475 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 372.96 | 223 | 83,170 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 516.96 | 223 | 115,282 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 316.08 | 218 | 68,905 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 447.84 | 293 | 131,217 | 76,106 | ||
Jun 15 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Option Exercise | J | 2.60 | 28,858 | 75,031 | 76,106 | ||
May 20 2021 | HEPA | Hepion Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 1.70 | 250,000 | 425,000 | 342,785 | |
Apr 09 2021 | VRPX | Virpax Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 4.62 | 13,183 | 60,905 | 13,183 | |
Mar 23 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Director | Buy | P | 10.40 | 470 | 4,886 | 21,922 | 21.5 K to 21.9 K (+2.19 %) |
Mar 23 2021 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Director | Buy | P | 10.42 | 1,900 | 19,804 | 21,452 | 19.6 K to 21.5 K (+9.72 %) |
Feb 19 2021 | VRPX | Virpax Pharmaceuti ... | JACOB GARY S | Director | Buy | P | 6.79 | 3,500 | 23,762 | 3,500 | 0 to 3.5 K |
Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 92,785 | |
Jun 19 2020 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Director | Option Exercise | A | 2.60 | 28,858 | 75,031 | 76,106 | |
May 18 2020 | XNOM.OB | Cardiff Oncology, ... | JACOB GARY S | Director | Buy | P | 1.43 | 17,483 | 25,001 | 19,552 | 2.1 K to 19.6 K (+845.00 %) |
Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 1.63 | 60,000 | 97,800 | 62,729 | |
Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 3.24 | 970 | 3,143 | 2,729 | |
Jun 24 2019 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | A | 2.48 | 44,734 | 110,940 | 48,071 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | JACOB GARY S | Director | Option Exercise | P | 1.55 | 8,625 | 13,369 | 8,625 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | JACOB GARY S | Director | Option Exercise | P | 1.55 | 15 | 23 | 15 | |
Jun 18 2018 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Executive Chairman | Option Exercise | M | 0.50 | 474,961 | 237,481 | 6,513,342 | |
Jun 18 2018 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Executive Chairman | Payment of Exercise | F | 0.00 | 150,246 | 0 | 595,460 | 745.7 K to 595.5 K (-20.15 %) |
Jun 18 2018 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Executive Chairman | Payment of Exercise | F | 0.00 | 131,934 | 0 | 745,706 | 877.6 K to 745.7 K (-15.03 %) |
Jun 18 2018 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Executive Chairman | Buy | M | 0.50 | 474,961 | 237,481 | 877,640 | 402.7 K to 877.6 K (+117.95 %) |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | A | 0.30 | 54,322 | 16,297 | 248,101 | |
Jan 09 2018 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Executive Chairman | Option Exercise | A | 2.18 | 950,000 | 2,071,000 | 6,988,303 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Buy | M | 0.00 | 16,667 | 0 | 148,954 | 132.3 K to 149 K (+12.60 %) |
Oct 05 2017 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | A | 0.72 | 38,106 | 27,436 | 193,779 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | M | 0.00 | 9,287 | 0 | 16,667 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Buy | M | 0.00 | 9,287 | 0 | 132,287 | 123 K to 132.3 K (+7.55 %) |
Jun 30 2017 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chairman and CEO | Option Exercise | A | 1.40 | 900,000 | 1,260,000 | 6,038,303 | |
Jun 30 2017 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chairman and CEO | Option Exercise | D | 1.40 | 900,000 | 1,260,000 | 5,138,202 | |
May 30 2017 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Buy | P | 3.52 | 5,680 | 19,967 | 402,679 | 397 K to 402.7 K (+1.43 %) |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Jul 20 2016 | CTRV | ContraVir Pharmace ... | JACOB GARY S | Director | Option Exercise | A | 1.04 | 65,000 | 67,600 | 1,015,000 | |
Jun 27 2016 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Option Exercise | A | 3.67 | 970,000 | 3,559,900 | 5,905,177 | |
Jan 06 2016 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | A | 5.18 | 16,000 | 82,880 | 155,673 | |
Sep 30 2015 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Option Exercise | A | 5.39 | 500,000 | 2,695,000 | 4,935,177 | |
Jul 28 2015 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Option Exercise | A | 7.91 | 300,000 | 2,373,000 | 4,435,177 | |
Jul 01 2015 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Option Exercise | M | 5.61 | 62,965 | 353,234 | 4,135,177 | |
Jul 01 2015 | SGYP | SYNERGY PHARMACEUT ... | JACOB GARY S | Chief Executive Off ... | Buy | M | 5.61 | 62,965 | 353,234 | 396,999 | 334 K to 397 K (+18.85 %) |
Mar 19 2015 | XNOM.OB | Trovagene, Inc. | JACOB GARY S | Director | Option Exercise | A | 7.18 | 16,000 | 114,880 | 139,673 |
Page: 1